Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception

American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice . Obstet Gynecol . 2016 Aug .

Show details Display options Display options Obstet Gynecol . 2016 Aug;128(2):e32-7. doi: 10.1097/AOG.0000000000001587.

Author

Collaborators

Item in Clipboard Full text links Cite Display options Display options

Abstract

Immediate postpartum long-acting reversible contraception (LARC) has the potential to reduce unintended and short-interval pregnancy. Women should be counseled about all forms of postpartum contraception in a context that allows informed decision making. Immediate postpartum LARC should be offered as an effective option for postpartum contraception; there are few contraindications to postpartum intrauterine devices and implants. Obstetrician-gynecologists and other obstetric care providers should discuss LARC during the antepartum period and counsel all pregnant women about options for immediate postpartum initiation. Education and institutional protocols are needed to raise clinician awareness and to improve access to immediate postpartum LARC insertion. Obstetrician-gynecologists and other obstetric care providers should incorporate immediate postpartum LARC into their practices, counsel women appropriately about advantages and risks, and advocate for institutional and payment policy changes to support provision.

Similar articles

[No authors listed] [No authors listed] Obstet Gynecol. 2016 Aug;128(2):422-423. doi: 10.1097/AOG.0000000000001583. Obstet Gynecol. 2016. PMID: 27454730

Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org; Vricella LK, Gawron LM, Louis JM. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, et al. Am J Obstet Gynecol. 2019 May;220(5):B2-B12. doi: 10.1016/j.ajog.2019.02.011. Epub 2019 Feb 7. Am J Obstet Gynecol. 2019. PMID: 30738885

Taub RL, Jensen JT. Taub RL, et al. Expert Opin Pharmacother. 2017 May;18(7):677-688. doi: 10.1080/14656566.2017.1316370. Epub 2017 Apr 17. Expert Opin Pharmacother. 2017. PMID: 28375776 Review.

Castleberry NM, Stark L, Schulkin J, Grossman D. Castleberry NM, et al. Contraception. 2019 Aug;100(2):123-127. doi: 10.1016/j.contraception.2019.03.053. Epub 2019 Apr 11. Contraception. 2019. PMID: 30981843

Goldthwaite LM, Shaw KA. Goldthwaite LM, et al. Curr Opin Obstet Gynecol. 2015 Dec;27(6):460-4. doi: 10.1097/GCO.0000000000000224. Curr Opin Obstet Gynecol. 2015. PMID: 26536209 Review.

Cited by

Cooper M, Black K, Cameron S. Cooper M, et al. Curr Opin Obstet Gynecol. 2024 Oct 1;36(5):331-337. doi: 10.1097/GCO.0000000000000982. Epub 2024 Aug 2. Curr Opin Obstet Gynecol. 2024. PMID: 39109628 Free PMC article. Review.

Ahrens KA, Palmsten K, Lipkind HS, Ackerman-Banks CM, Grantham CO. Ahrens KA, et al. Ann Epidemiol. 2024 Aug;96:58-65. doi: 10.1016/j.annepidem.2024.06.001. Epub 2024 Jun 15. Ann Epidemiol. 2024. PMID: 38885800

Nepal S, Acharya S, Marhatta A, Shrestha S. Nepal S, et al. JNMA J Nepal Med Assoc. 2023 Sep 1;61(265):714-717. doi: 10.31729/jnma.8254. JNMA J Nepal Med Assoc. 2023. PMID: 38289806 Free PMC article.

Levandowski BA, Green T, Liu L, Betstadt S, Thevenet-Morrison K, Harrington A. Levandowski BA, et al. Matern Child Health J. 2023 Nov;27(11):1914-1919. doi: 10.1007/s10995-023-03738-w. Epub 2023 Jun 8. Matern Child Health J. 2023. PMID: 37289295

Sothornwit J, Kaewrudee S, Somboonporn W, Seanbon O, Ngamjarus C. Sothornwit J, et al. Heliyon. 2023 May;9(5):e16242. doi: 10.1016/j.heliyon.2023.e16242. Epub 2023 May 13. Heliyon. 2023. PMID: 37229160 Free PMC article.